Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A
Mol Cancer. 2025; 24(1):58.
PMID: 40011944
PMC: 11863469.
DOI: 10.1186/s12943-025-02267-0.
Thapa R, Marianesan A, Rekha A, Ganesan S, Kumari M, Bhat A
Biogerontology. 2025; 26(2):64.
PMID: 40011266
PMC: 11865175.
DOI: 10.1007/s10522-025-10208-z.
Arjsri P, Srisawad K, Umsumarng S, Thippraphan P, Anuchapreeda S, Dejkriengkraikul P
Biomolecules. 2025; 15(1).
PMID: 39858497
PMC: 11763329.
DOI: 10.3390/biom15010103.
Alsharoh H, Chiroi P, Isachesku E, Tanasa R, Pop O, Pirlog R
Biomedicines. 2024; 12(7).
PMID: 39062063
PMC: 11275062.
DOI: 10.3390/biomedicines12071489.
Wang Y, Ran T, Li Y, Tian L, Yang L, Liu Z
Aging (Albany NY). 2024; 16(12):10348-10365.
PMID: 38874497
PMC: 11236306.
DOI: 10.18632/aging.205932.
The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression.
Pandya D, Parikh R, Gena R, Kothari N, Parekh P, Chorawala M
Mol Biol Rep. 2024; 51(1):701.
PMID: 38822973
DOI: 10.1007/s11033-024-09653-9.
Unravelling the Triad of Lung Cancer, Drug Resistance, and Metabolic Pathways.
Mohanty P, Pande B, Acharya R, Bhaskar L, Verma H
Diseases. 2024; 12(5).
PMID: 38785748
PMC: 11119248.
DOI: 10.3390/diseases12050093.
Potential mechanism of Chai Gui Zexie Decoction for NSCLC treatment assessed using network pharmacology, bioinformatics, and molecular docking: An observational study.
Lin M, Zhao A, Chen B
Medicine (Baltimore). 2024; 103(20):e38204.
PMID: 38758858
PMC: 11098237.
DOI: 10.1097/MD.0000000000038204.
Elucidating the anti-cancer potential of essential oil against non-small cell lung cancer: A multifaceted approach involving GC-MS profiling, network pharmacology, and molecular dynamics simulations.
Mohanty D, Padhee S, Priyadarshini A, Champati B, Das P, Jena S
Heliyon. 2024; 10(6):e28026.
PMID: 38533033
PMC: 10963383.
DOI: 10.1016/j.heliyon.2024.e28026.
Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathway.
Lu T, Zhou L, Chu Z, Song Y, Wang Q, Zhao M
Chin Med. 2024; 19(1):54.
PMID: 38528546
PMC: 10962170.
DOI: 10.1186/s13020-024-00895-0.
miR-147b mediated suppression of DUSP8 promotes lung cancer progression.
Turkowski K, Herzberg F, Gunther S, Weigert A, Haselbauer T, Fink L
Oncogene. 2024; 43(16):1178-1189.
PMID: 38396293
PMC: 11014796.
DOI: 10.1038/s41388-024-02969-7.
DriverMP enables improved identification of cancer driver genes.
Liu Y, Han J, Kong T, Xiao N, Mei Q, Liu J
Gigascience. 2023; 12.
PMID: 38091511
PMC: 10716827.
DOI: 10.1093/gigascience/giad106.
Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer.
Le M, Nguyen H, Nguyen X, Do X, Mai B, Ngoc Nguyen H
Heliyon. 2023; 9(11):e22080.
PMID: 38058618
PMC: 10696070.
DOI: 10.1016/j.heliyon.2023.e22080.
Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma.
Hasan G, Hassan M, Sohal S, Shamsi A, Alam M
ACS Omega. 2023; 8(30):26685-26698.
PMID: 37546685
PMC: 10398694.
DOI: 10.1021/acsomega.3c02424.
The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis.
Wang L, Liu W, Liu K, Wang L, Yin X, Bo L
Mol Ther Nucleic Acids. 2022; 30:633-647.
PMID: 36514354
PMC: 9722404.
DOI: 10.1016/j.omtn.2022.11.019.
Dostarlimab an Inhibitor of PD-1/PD-L1: A New Paradigm for the Treatment of Cancer.
Alkholifi F, Alsaffar R
Medicina (Kaunas). 2022; 58(11).
PMID: 36363529
PMC: 9694305.
DOI: 10.3390/medicina58111572.
Overview of Ca signaling in lung cancer progression and metastatic lung cancer with bone metastasis.
Tran M
Explor Target Antitumor Ther. 2022; 2(3):249-265.
PMID: 36046435
PMC: 9400727.
DOI: 10.37349/etat.2021.00045.
Molecular mechanism of Rhubarb in the treatment of non-small cell lung cancer based on network pharmacology and molecular docking technology.
Tan Y, Lu Y
Mol Divers. 2022; 27(3):1437-1457.
PMID: 35933455
DOI: 10.1007/s11030-022-10501-w.
Role of platelet rich plasma mediated repair and regeneration of cell in early stage of cardiac injury.
Imam S, Al-Abbasi F, Hosawi S, Afzal M, Nadeem M, Ghoneim M
Regen Ther. 2022; 19:144-153.
PMID: 35229012
PMC: 8856949.
DOI: 10.1016/j.reth.2022.01.006.
Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway.
Jain A, Prasad A, Pradeep S, Dharmashekar C, Achar R, Ekaterina S
Front Oncol. 2021; 11:741326.
PMID: 34692523
PMC: 8526962.
DOI: 10.3389/fonc.2021.741326.
